Učitavanje...

Cholesterol Efflux Capacity, Macrophage Reverse Cholesterol Transport, and Cardioprotective HDL

PURPOSE OF REVIEW: Randomized clinical trials provide strong evidence that pharmacological elevation of HDL-cholesterol (HDL-C) fails to reduce cardiovascular disease risk in statin-treated humans. It is thus critical to identify new metrics that capture HDL's cardioprotective effects. RECENT F...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Curr Opin Lipidol
Glavni autori: Hutchins, Patrick M., Heinecke, Jay W.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4617325/
https://ncbi.nlm.nih.gov/pubmed/26270810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000209
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!